What Will Retailtainment Look Like Post-Pandemic?

Whether you’re an integrator, a designer or simply a label-defying creative, the EXPERIENCE is everything. Host Bryan Meszaros explores the story behind the exhibit to understand how a carefully crafted experience traps into the human experience to connect people to place.

 

On this episode of Experience By Design, Host Bryan Meszaros talked with David Title, Partner at Bravo Media, a multi-platform creative studio focused on enhanced engagement through dynamic experiences. Meszaros and Title spoke about Title’s career, Bravo’s work, and retail during the pandemic and post-pandemic, including working on Krispy Kreme’s flagship store in Times Square.

While working on the project, they came across a lot of fresh donuts that had to be consumed. There’s nothing better than the Original Glaze, according to Title. They were fresh off the line. He just wishes the projects at Mercedes and Lincoln also offered free examples.

“We look at shopping as an entertainment, as a thing to do. As much as it is a way to acquire something, which is why a lot of people go shopping and come home with nothing.” – David Title

The first thing they jumped into was talking shop about work after the pandemic. Title’s team is starting to inquiries pick up, as more projects are picking up and businesses are starting to plan again. Aside from things being closed, there wasn’t much confidence in any sector, Title said. But, as things have gotten a bit more under control, they’re starting to look ahead. They even have a crew headed to Miami to work on a party activation.

One of the things he noticed during the pandemic is that people could still get everything they need online. There wasn’t an acquisition of stuff, but now that stores are open, what is the need for consumers to return to the store? Retailers will have to make shopping into something we do for the pleasure of being in the environment, Title said.

“We look at shopping as an entertainment, as a thing to do,” Title said. “As much as it is a way to acquire something, which is why a lot of people go shopping and come home with nothing.”

Join host Bryan Meszaros on Experience by Design every other Wednesday as he explores the latest trends and solutions, helping craft the world’s most intriguing experiences.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More